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Abstract
The target effects on the expression of epithelial-mesenchymal transition regulation molecules are promising for cancer 
therapy, including breast cancer. 3D cell culture is a model for studying epithelial-mesenchymal transition in vitro and may become 
a test system for anticancer therapy.
Aim of research. The aim of this research was to evaluate and compare the expression of tumor associated and epitheli-
al-mesenchymal transition markers in tumor cells of breast adenocarcinoma (MCF-7 cell line) in 2D and 3D cell culture.
Methods. For realization of the aim MCF-7 cell line (breast adenocarcinoma) was chosen as an experimental model in vitro. 
The monolayer cell culture was cultured in standard conditions (37 oC, 5 % CO2, humidity 95 %). The initial density of inoculated cells 
was 2×104 cells/cm2. The cells were incubated for two days before their use in the experiment. For the initial generation of spheroids 
the monolayer cell culture was removed off the substrate after the four days of incubation, using 0,25 % Trypsin-EDTA, and placed in 
nutrient medium with 5 % carboxymethyl cellulose (Bio-Rad, USA) at concentration of 5×105 cells/ml. Then the plates were incubated 
on an orbital shaker (Orbital shaker, PSU-10i, Biosan, Latvia) at 50 rpm for 3–5 hours. Half of culture medium was replenished every 
3 days. A spheroid culture was maintained for 14 days. Detection of markers (ER, p53, EpCAM, vim, AE1/AE3, panCK, EGFR) in 2D 
and 3D cell culture was performed using immunohistochemistry method with primary monoclonal antibodies. Histological samples of 
cells were photographed to compare the morphological characteristics and the expression of proteins in monolayer and spheroid culture
Results. The results demonstrated that the percentage of tumor marker positive cells (ER+, EGFR+, EpCAM+, panCK+, 
AE1/AE3+) in monolayer culture is 1.25–2 times than more in spheroid culture. In contrast, tumor spheroids consist of fewer cells 
with the expression of epithelial markers such as EpCAM and AE1/AE3, but they contain a large number of cells that expressed mes-
enchymal marker vimentin by 5 % and p53 by 10 %. This may indicate that the cells acquire a mesenchymal phenotype. However, 
tumor cells of monolayer cell culture were not expressed vimentin.
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Conclusions. Our results demonstrated the differences of expression of tumor associated and epithelial-mesenchymal tran-
sition markers in 2D and 3D breast cancer cell cultures. Thus, the percentage of epithelial markers (Cytokeratines and epithelial cell 
adhesion molecule) in tumor spheroids is less than in cells of monolayer however spheroids cells begin expressing a mesenchymal 
marker – vimentin. In 3D cell culture only the outer cell layers expressed tumor associated proteins unlike 2D cell culture in which 
all of cells showed equally expression. Reduced of manifestation of tumor associated markers in 3D cell culture may indicate an 
increase of stem properties. These data showed that 3D cell culture more than 2D cell culture characterized processes of epithelial- 
mesenchymal transition. 
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1. Introduction
Cancer cell lines are widely used in cancer development studies and for testing of the anti- 
cancer drugs. Recent studies have shown that the most adequate model of the tumor population 
in vitro is a multilayer (3D) cell culture (multicellular tumor spheroids, MCTS) [1]. MCTS model is 
helpful for understanding of disease development mechanisms, invasion, metastasis and resistance 
to anticancer therapy [2]. In the tissue in vivo tumor cells have strong connections with neighboring 
cells and the extracellular matrix. Also, the 3D cell cultures are useful for evaluating the impact of 
cell-cell interactions on tumor development in vitro. Tumor cells in 3D cultures actively interact 
with each other, with the extracellular matrix and microenvironment. These interactions affect the 
proliferation, differentiation, cell morphology, gene expression and protein synthesis. The struc-
ture of MCTS is similar to the micro metastases or tumor at early avascular stage. Furthermore, 
3D spheroids are composed of cells at different stages of development and under influence of var-
ious factors (proliferating, dormant, apoptotic and necrotic cells) [3]. The most outer layers of 
spheroid consist of actively proliferating cells, but core contains of dormant or necrotic cells, be-
cause these cells receive less oxygen, growth factors and nutrients. Other differences between 2D 
and 3D cell cultures are gene expression level, proliferation rate, migration ability and resistance 
to anticancer therapy [4]. Unlike monolayer, cells of spheroid show less ability to apoptosis, which 
is caused by radio- or chemotherapy, due to the reduction or blocking of cell death receptor ex-
pression [5]. 3D cell culture spatial architecture plays an important role in the testing of anticancer 
drugs therapeutic effect, and in evaluation of the invasive capacity of the transformed cells.
In addition, we suppose that the study of changes in the phenotype of tumor cells from 
epithelial to mesenchymal in MCTS is very relevant. The process by which epithelial cells lose 
their cell polarity and cell-cell adhesion, and gain migratory and invasive properties to become 
mesenchymal stem cells is called epithelial-mesenchymal transitions (EMT) and is the object of 
primary interest for the development of anti-tumor therapy. EMT is a key process for embryonic 
development, as well as tissue regeneration and tumor progression process in an adult organism. 
Tumor cells that are exposed to EMT can inhibit antitumor mechanisms of the organism, mi-
grate, do not respond to apoptosis, and do not react to the action of anticancer drugs. These cells 
act as a reservoir which replenishes the tumor cell population [6]. EMT phenomenon explained 
the reasons for the formation of distant metastases of tumors of epithelial origin, including breast 
cancer (BC). Features of EMT are the destruction of cell-cell contacts, which leads to the loss 
of epithelial characteristics and formation of mesenchymal morphology [7]. EMT-cells actively 
proliferate and self-renew, resulting in increased amount of heterogeneous populations. As a 
result, cell motility increased and metastatic colonies in distant places are formed [8]. Thus, the 
target effect on the expression of molecules that regulate EMT is promising for cancer therapy, 
including breast cancer. 
2. Aim of research
The aim of this study was to evaluate and compare the expression of major EMT markers in 
tumor cells of breast adenocarcinoma (MCF-7 cell line) in 2D and 3D cell culture.
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3. Materials and methods
An MCF-7 cell line (breast adenocarcinoma) was kindly offered by the bank of Cell Lines 
from Human and Animal Tissues, Kavetsky` Institute of Experimental Pathology, Oncology and 
radiobiology, National Academy of Science of Ukraine. The monolayer cell culture was cultured in 
standard conditions (37 oC, 5 % CO2, humidity 95 %), using DMEM nutrient medium (Dulbecco’s 
Modified Eagle Medium, “Sigma», USA) with 10 % fetal serum (Sigma, USA), 2 mM L-Glutamine 
(Sigma, USA), and 40 mg Gentamicin (Biopharma, Ukraine). The initial density of inoculated cells 
was 2×104  cells/cm2. The cells were incubated for two days before their use in the experiment.
For the initial generation of spheroids the monolayer cell culture was removed off the sub-
strate after the four day incubation, using 0,25 % Trypsin-EDTA, and placed in nutrient medium 
with 5 % carboxymethyl cellulose (Bio-Rad, USA) at concentration of 5×105 cells/ml. Then the 
plates were incubated on an orbital shaker (Orbital shaker, PSU-10i, Biosan, Latvia) at 50 rpm for 
3–5 hours. Half of culture medium was replenished every 3 days. A spheroid culture was main-
tained for 14 days. Further MCTS for immunohistochemical assay were obtained from paraffin 
blocks. Sections were cut from each block, dewaxed in xylene, and then hydrated using graded 
concentrations of ethanol in distilled water. Microwave antigen retrieval was performed before 
incubation with primary antibodies at room temperature for 5 min. Samples were incubated with 
each antibody. 
To evaluate the expression of EMT markers in monolayer culture cells were seeded on cover 
glass in 6-well plates (Flat bottom cell+, Sarstedt, USA) at a density of 2×104 cells/cm2. Detection 
of markers in 2D and 3D cell culture was performed using immunohistochemistry method with pri-
mary monoclonal antibodies: Cytokeratin (clone AE1/AE3, Dako, USA), PanCytokeratin 5/6/8/18 
(clone 5D3 and LP34, Dako, USA), ERα (clone EP1, Dako, USA), EGFR (Dako, USA), EpCAM (ep-
ithelial cell adhesion molecule), (Sigma, Sweden), p53 (tumor suppressor protein)(Sigma, Sweden). 
Visualization of proteins was performed according to the manufacturer’s recommendations using 
the system PolyVue HRP/DAB Detection system (“DiagnosticBioSystem”, USA, № PV100D). His-
tological samples of the cells were photographed to compare the morphological characteristics and 
the expression of proteins in monolayer and spheroid culture (origin magnification ×100, Cannon, 
Stemi 2000, Zeiss). 
4. Results of research
As shown in Table 1, the significant difference was observed in the expression of tumor 
associated markers (ER, p53, vim, EpCAM, Cks and EGFR) in 2D and 3D cell cultures. Notably, a 
uniform diffusive distribution of markers was shown in 2D cell culture (Fig. 1–7, b). As apposed, 
in cell aggregates outer cell layers expressing these markers (Fig. 1–7, a).
Table 1
Expression of main markers of epithelial-mesenchymal transition in 2D and 3D cell culture (breast 
adenocarcinoma, MCF-7)
Markers 3D cell culture, % of cells 2D cell culture, % of cells
“+” “±” “–” “+” “±” “–”
EGFR 10 15 75 75 20 5
EpCAM 3 10 87 60 25 15
ER 20 20 60 56 40 4
panCK 30 15 55 95 5 0
Vim 5 5 90 0 0 100
p53 60 30 10 50 45 5
AE1/AE3 5 10 85 100 0 0
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                                 a                                                                                         b
Fig. 1. EGFR expression in MCF-7 cell line, breast adenocarcinoma:  
а – in 3D cell culture; b – in 2D cell culture
                                     a                                                                                    b
Fig. 2. EpCAM expression in MCF-7 cell line, breast adenocarcinoma:  
а – in 3D cell culture; b – in 2D cell culture
                                  a                                                                                       b
Fig. 3. ER expression in MCF-7 cell line, breast adenocarcinoma:  
а – in 3D cell culture; b – in 2D cell culture
According to literature data [9] actively proliferating cells are in the spheroid outer cell layers. 
Such cell distribution may be caused not only by the limited diffusion substances into the inner layers 
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of the spheroid, but with the heterogeneity of the population and functional cellular composition. On the 
one hand increasing of the cell subpopulations number may be caused by EMT, but on the other hand it is 
caused by a small subpopulation of tumor stem cells, that closely related to invasion and metastasis [10].
                                   a                                                                                        b
Fig. 4. Pan-CK expression in MCF-7 cell line, breast adenocarcinoma:  
а – in 3D cell culture; b – in 2D cell culture
                                    a                                                                                      b
Fig. 5. Vim expression in MCF-7 cell line, breast adenocarcinoma:  
а – in 3D cell culture; b – in 2D cell culture
                                     a                                                                                     b
Fig. 6. P53 expression in MCF-7 cell line, breast adenocarcinoma:  
а – in 3D cell culture; b – in 2D cell culture
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                                    a                                                                                       b
Fig. 7. AE1/AE3 expression in MCF-7 cell line, breast adenocarcinoma:  
а – in 3D cell culture; b – in 2D cell culture
As shown in Fig. 8, the percentage of marker positive cells (ER+, EGFR+, EpCAM+, 
panCK+, AE1/AE3+) in monolayer culture is 1.25–2 times more than in spheroid culture. Reduced 
of manifestation of tumor associated markers in 3D cell culture may indicate an increase of stem 
properties. In contrast, tumor spheroids consist of fewer cells with the expression of epithelial 
markers such as EpCAM and AE1/AE3, but they contain a large number of cells that expressed 
mesenchymal marker vimentin by 5 % and and p53 by 10 %. This may indicate that the cells 
acquire a mesenchymal phenotype. However, tumor cells of monolayer cell culture were not ex-
pressed vimentin (Fig. 8). Unfortunately, we are not investigated all of mesenchymal markers of 
epithelial-mesenchymal transition, but it will be our next objective.
The results of our work are in good agreement with the literature data [11]. Therefore, our 
data showed that the 3D cell culture more than 2D cell culture characterized processes of epiteli-
al-mesenchymal transition.
Fig. 8. Changes in the expression of markers of epithelial-mesenchymal transition in 2D and 3D 
cell culture MCF-7, % “+” and “–” cells
5. Discussion of results of research
Originally, breast tumor derived from epithelial tissue, which is characterized by a multi-lay-
er morphology with apical-basal polarity. However, the mesenchymal tissue has no polarity. At the 
same time in the mesenchymal cells increased the expression of mesenchymal associated molecules 
N-cadherin, fibronectin and vimentin [12]. EMT closely related to EpCAM expression (epithelial 
cell adhesion molecule). Such tumor tissue as primary and metastatic breast cancer has high ex-
pression levels of EpCAM that is associated with poor prognosis, cell proliferation, migration and 









possibly the initiation of cancer [13]. EpCAM expression modulation is a way to influence the onco-
genic potential of tumor cells for certain types of tumors [14]. EpCAM has been recently identified 
as an additional marker for tumor-associated stem cells. Cancer cells that express EpCAM have 
greater oncogenic potential than EpCAM-negative cells. Vimentin is another important molecule 
of mesenchymal origin, which takes part in the EMT. This molecule is found in epithelial cells in-
volved in the physiological or pathological processes that require migration of epithelial cells [15]. 
Vimentin’s overexpression in cancer correlates well with accelerated tumor growth, invasion, and 
poor prognosis. Although EMT is associated with several tumorigenic events, vimentin’s role in 
the underlying events mediating these processes remains unknown. By virtue of its overexpression 
in cancer and its association with tumor growth and metastasis, vimentin serves as an attractive 
potential target for cancer therapy [16]. Consequently, EMT is caused by a wide range of molecu-
lar processes. One of these processes have the binding of growth factors such as EGF (epidermal 
growth factor), with a specific receptor (EGFR) on the cell surface. Thus, such binding leads to 
the receptor activation and stimulation of EMT in breast tumor cells [17]. Thereby, it changes the 
expression of vimentin and E-cadherin [18]. Scientists have shown that inhibition of EGFR expres-
sion leads to the suppression of EMT and reduction ability, migration and invasion of tumor cells 
[19]. In contrast, EGFR activation increases the expression of vimentin (mesenchymal marker) and 
reduces the expression of pan-cytokeratins (epithelial markers) [20]. Recent studies have shown 
that an important role in the regulation of EMT plays proapoptotic protein p53. It is a transcription 
factor and it regulates expression of genes that promote apoptosis, aging and cell cycle arrest [21]. 
The ability of p53 to regulate metastasis, migration and invasion occurs by modulating of EMT and 
suppression of the basic properties of cancer stem cells (CSC) [22]. 
6. Conclusion
In this study we compared the expression of markers of epithelial-mesenchymal transition 
in monolayer and spheroid cell culture of breast adenocarcinoma. The results showed differences 
in the expression of EMT markers in 2D and 3D culture. Thus, the percentage of epithelial markers 
(Cks and EpCAM) in tumor spheroids is less than in cells of monolayer however spheroids cells 
begin expressing a mesenchymal marker – vimentin. In 3D cell culture only the outer cell layers 
expressed EMP proteins unlike 2D cell culture in which all of cells showed equally expression. It is 
evident, that these two cell cultures have differences in marker expression, and, as we have shown 
previously [23], in morphology, proliferation, and response to anticancer drugs.
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